Key Highlights
- ARK Invest acquired 34,080 Meta Platforms shares valued at $20.55 million on July 9, 2026
- The investment preceded Meta’s anticipated Q2 earnings announcement scheduled for July 29
- ARK divested 10,774 AMD shares worth $5.57 million, extending its weeklong selloff
- The firm also purchased 217,896 Circle Internet Group shares across three ETFs totaling $13.96 million
- Analysts rate Meta as a Strong Buy with a consensus price target of $817.15
Cathie Wood’s investment firm, ARK Invest, executed several significant portfolio adjustments on Thursday, July 9, 2026. The firm’s most substantial transaction involved a $20.55 million stake in Meta Platforms through its ARK Innovation ETF.
The investment firm secured 34,080 shares of Meta stock. This strategic purchase arrives just ahead of Meta’s scheduled second-quarter financial results on July 29.
Analysts on Wall Street project Meta will deliver earnings of $7.17 per share alongside revenue reaching $60.19 billion during the quarter.
ARK’s Bet on Meta’s Artificial Intelligence Strategy
The acquisition followed several major AI-focused developments from Meta. The technology giant introduced Muse Spark 1.1, marking its first commercially available AI model, along with additional AI capabilities designed for enterprise clients.
Meta revealed that its proprietary AI chip, dubbed Iris, will enter full-scale production this September. Additionally, the company disclosed intentions to allocate over $13 billion toward constructing a new data facility in Alberta, Canada.
According to TipRanks, Meta carries a Strong Buy consensus rating from analysts, with 34 Buy recommendations and five Hold ratings. The $817.15 average price target suggests potential upside of approximately 29.4% from present levels. Meta’s stock has declined 4.2% so far this year.
ARK Reduces AMD Position Alongside Other Holdings
Regarding divestments, ARK liquidated 10,774 Advanced Micro Devices shares through the ARKK ETF. The transaction amounted to $5.57 million. This represents an ongoing reduction in AMD exposure, with ARK decreasing its stake throughout the previous week.
The investment firm also disposed of 85,319 Robinhood Markets shares valued at $9.69 million and 70,154 Roku shares totaling $9.77 million.
Twist Bioscience holdings were similarly reduced, with ARK selling 98,776 shares worth $8.83 million.
In addition to Meta, ARK expanded its Circle Internet Group holdings. The firm acquired 217,896 shares distributed across its ARKK, ARKW, and ARKF ETFs, representing a combined investment of $13.96 million.
ARK additionally purchased 105,364 Ionis Pharmaceuticals shares for $8.9 million and 544,385 Prime Medicine shares valued at $2.52 million.
Smaller acquisitions encompassed 57,462 Generate Biomedicines shares costing $911,921 and 46,302 Compass Pathways shares worth $646,838.
Meta’s stock price surged 6.58% on July 10, following the public disclosure of ARK’s investment.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
